Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $182.25 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $55.34 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $33.00 | 1 | $0 (2017) |
| Hoffmann-La Roche Limited | $25.00 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $18.67 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $17.38 | 1 | $0 (2021) |
| Lundbeck LLC | $16.49 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $16.37 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $51.53 | 3 | AstraZeneca Pharmaceuticals LP ($18.67) |
| 2021 | $42.38 | 2 | Hoffmann-La Roche Limited ($25.00) |
| 2018 | $55.34 | 1 | Lilly USA, LLC ($55.34) |
| 2017 | $33.00 | 1 | Janssen Pharmaceuticals, Inc ($33.00) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Central Nervous System | ||||||
| 01/26/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2021 | Hoffmann-La Roche Limited | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 03/04/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: UROLOGY | ||||||
| 11/10/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $55.34 | General |
| Category: Diabetes | ||||||
| 03/17/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 104 | 120 | $15,359 | $6,836 |
| 2021 | 4 | 232 | 398 | $59,624 | $29,647 |
| 2020 | 5 | 235 | 629 | $72,000 | $32,642 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $4,783 | $2,676 | 56.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 56 | $5,803 | $2,479 | 42.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 30 | 30 | $3,993 | $1,232 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $779.24 | $448.70 | 57.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 89 | 192 | $28,724 | $14,682 | 51.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 78 | 136 | $20,400 | $7,796 | 38.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 34 | 39 | $5,850 | $4,680 | 80.0% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Facility | 2021 | 31 | 31 | $4,650 | $2,489 | 53.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 93 | 255 | $38,250 | $14,052 | 36.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 70 | 290 | $21,150 | $10,369 | 49.0% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 20 | 31 | $4,650 | $3,689 | 79.3% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Facility | 2020 | 38 | 38 | $5,700 | $2,970 | 52.1% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 14 | 15 | $2,250 | $1,561 | 69.4% |
About Dr. Mary Schuler, MD
Dr. Mary Schuler, MD is a Internal Medicine healthcare provider based in Wyncote, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609814813.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Schuler, MD has received a total of $182.25 in payments from pharmaceutical and medical device companies, with $51.53 received in 2023. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($182.25).
As a Medicare-enrolled provider, Schuler has provided services to 571 Medicare beneficiaries, totaling 1,147 services with total Medicare billing of $69,125. Data is available for 3 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wyncote, PA
- Active Since 06/02/2006
- Last Updated 09/16/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609814813
Products in Payments
- TRULICITY (Drug) $55.34
- XARELTO (Drug) $33.00
- FARXIGA (Drug) $18.67
- MYRBETRIQ (Drug) $17.38
- REXULTI (Drug) $16.49
- AUSTEDO (Drug) $16.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyncote
Stephen Margolis, Md, MD
Internal Medicine — Payments: $1,352
Aribelle Jones, M.d, M.D
Internal Medicine — Payments: $17.09
Dr. Alan Bilsky, Md, MD
Internal Medicine — Payments: $11.18
Dr. Melissa Schiffman, Md, MD
Internal Medicine
Dr. Donald Liss, Md, MD
Internal Medicine